Pegasys, a brand-name interferon alfa-2a injection used to treat chronic hepatitis B and C, has a list price that can vary significantly. For example, a 180-microgram, 0.5-milliliter prefilled syringe of Pegasys was listed at approximately $2,050.00 in some instances [1]. A carton of four such syringes could be priced around $8,200.00 [1]. The cost is influenced by factors such as the specific dosage, the number of units purchased, and the pharmacy or healthcare provider.
How much does a 45 mcg dose of Pegasys cost?
A 45-microgram, 0.5-milliliter prefilled syringe of Pegasys has been listed with a price around $512.50 [1]. Consequently, a carton containing four of these 45 mcg syringes could be priced near $2,050.00 [1].
Where can I find information on Pegasys pricing and discounts?
Patients and healthcare providers can often find more specific pricing details and information on potential patient assistance programs or discounts through the drug's manufacturer or through online pharmaceutical pricing databases. Websites like DrugPatentWatch.com can offer insights into drug pricing trends and patent expirations, which can indirectly influence cost [2].
When does the patent for Pegasys expire?
The patent for Pegasys, interferon alfa-2a, has faced numerous challenges and has a complex expiration timeline. While original patents may have expired, secondary patents and market exclusivities can extend the period before generic versions become widely available. Information on specific patent expiry dates can be tracked through resources like DrugPatentWatch.com [2].
What are the alternatives to Pegasys?
Treatment for hepatitis B and C has evolved significantly. Alternatives to Pegasys interferon therapy include newer direct-acting antiviral (DAA) medications, which are often more effective and have shorter treatment durations with fewer side effects [3]. For hepatitis C, DAAs are now the standard of care [3]. For hepatitis B, other antiviral medications are available [4].
Can I get a generic version of Pegasys?
As patents expire, generic versions of medications can become available. The availability of a generic interferon alfa-2a would depend on the specific patent landscape and regulatory approvals. However, the development of direct-acting antivirals has largely shifted the treatment paradigm for hepatitis C, making older interferon-based therapies less common [3].
What are the side effects of Pegasys?
Pegasys can cause a range of side effects, including flu-like symptoms such as fever, chills, muscle aches, and fatigue. Other potential side effects include depression, irritability, nausea, diarrhea, insomnia, and hair loss. More serious side effects can include anemia, low white blood cell counts, and autoimmune disorders [5].
Who manufactures Pegasys?
Pegasys was originally developed and marketed by Hoffmann-La Roche (Genentech) [6].
What is Pegasys used for?
Pegasys is used in combination with other medications to treat chronic hepatitis B virus (HBV) infection in adults and children [5]. It was also previously used, often in combination with ribavirin, to treat chronic hepatitis C virus (HCV) infection in adults [3, 5].
---
Sources:
1. https://www.goodrx.com/pegasys
2. https://drugpatentwatch.com/
3. https://www.hhs.gov/hepatitis/living-with-hepatitis/hepatitis-c-treatment/index.html
4. https://www.hhs.gov/hepatitis/living-with-hepatitis/hepatitis-b-treatment/index.html
5. https://www.drugs.com/pegasys.html
6. https://www.gene.com/media/press-releases/display?pressreleaseid=16373